Literature DB >> 26676820

Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.

Ashley E Stueck1, Zhenhong Qu2, Mary Ann Y Huang3, Genís Campreciós4, Linda D Ferrell5, Swan N Thung1.   

Abstract

Hepatocyte nuclear factor-1α mutated hepatocellular adenomas (H-HCA) are thought to have no to minimal malignant potential. This report describes a 23-year-old woman with maturity-onset diabetes of the young who developed a 12.5-cm hepatic mass with a radiographically and pathologically distinct 3.0-cm region. Histologically and immunohistochemically, the bulk of the mass was an H-HCA with extensive pseudoglandular formation and only focal steatosis. The 3.0-cm nodule showed small cell change, thickened hepatocyte plates, pleomorphic and hyperchromatic nuclei, reticulin loss, and stromal and vascular invasion, diagnostic of hepatocellular carcinoma (HCC). Immunohistochemically, increased expression of glutamine synthetase in tumor cells and CD34 expression in sinusoidal endothelial cells were seen in the HCC component. Nuclear expression of β-catenin, and exon 3 of CTNNB1 and TERT promoter mutations were absent in this case. Thus, we report a HCC arising in an H-HCA; although cases appear exceedingly rare, they reinforce the potential of H-HCA for malignant transformation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26676820     DOI: 10.1055/s-0035-1567827

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  9 in total

1.  Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Authors:  Juan Putra; Linda D Ferrell; Annette S H Gouw; Valerie Paradis; Arvind Rishi; Christine Sempoux; Charles Balabaud; Swan N Thung; Paulette Bioulac-Sage
Journal:  Mod Pathol       Date:  2019-09-30       Impact factor: 7.842

2.  Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.

Authors:  Jaclyn F Hechtman; Ghassan K Abou-Alfa; Zsofia K Stadler; Diana L Mandelker; Michael H A Roehrl; Ahmet Zehir; Efsevia Vakiani; Sumit Middha; David S Klimstra; Jinru Shia
Journal:  Hum Pathol       Date:  2018-08-17       Impact factor: 3.466

3.  Hepatocellular adenoma: Where are we now?

Authors:  Xi Wang; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

Review 4.  Hepatocellular adenoma: when and how to treat? Update of current evidence.

Authors:  Maarten G Thomeer; Mirelle Broker; Joanne Verheij; Michael Doukas; Turkan Terkivatan; Diederick Bijdevaate; Robert A De Man; Adriaan Moelker; Jan N IJzermans
Journal:  Therap Adv Gastroenterol       Date:  2016-09-28       Impact factor: 4.409

Review 5.  Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma.

Authors:  Chun Gao
Journal:  World J Hepatol       Date:  2016-09-28

6.  Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia.

Authors:  Hyo Jeong Kang; Hui Jeong Jeong; So-Woon Kim; Eunsil Yu; Young-Joo Lee; So Yeon Kim; Jihun Kim
Journal:  J Pathol Transl Med       Date:  2017-12-27

Review 7.  Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.

Authors:  Elan Hahn; Juan Putra
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

8.  Clinicopathological features and post-resection outcomes of hepatocellular adenoma.

Authors:  Sung-Min Kim; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Seung-Mo Hong
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-02-28

Review 9.  Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.

Authors:  Massimo Roncalli; Amedeo Sciarra; Luca Di Tommaso
Journal:  Clin Mol Hepatol       Date:  2016-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.